A real world retrospective longitudinal observational cohort study assessing the Immune Thrombocytopenia treatment patterns and the long-term safety of persistent use of Eltrombopag compared to corticosteroids
Latest Information Update: 24 Aug 2021
At a glance
- Drugs Eltrombopag (Primary) ; Corticosteroids
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 24 Aug 2021 New trial record
- 01 Aug 2021 Results published in the International Journal of Hematology